Explore more publications!
Healthy Living Maldives
Got News to Share?

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on November 19, 2025

Profusa Announces Third Quarter Business and Financial Highlights
Nov. 19, 2025

Profusa Announces Third Quarter Business and Financial Highlights

Indeterminate GlobeNewswire
Apollomics Announces Settlement of Cayman Litigation
Nov. 19, 2025

Apollomics Announces Settlement of Cayman Litigation

Indeterminate GlobeNewswire
FDA Pilots Faster Clarifications to Meeting Minutes
Nov. 19, 2025

FDA Pilots Faster Clarifications to Meeting Minutes

Indeterminate GlobeNewswire
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nov. 19, 2025

Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
Nov. 19, 2025

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Indeterminate GlobeNewswire
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results
Nov. 19, 2025

ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
Nov. 19, 2025

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

Indeterminate GlobeNewswire
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nov. 19, 2025

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart
Nov. 19, 2025

SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart

Indeterminate GlobeNewswire
Meihua International Announces 1-For-100 Reverse Share Split
Nov. 19, 2025

Meihua International Announces 1-For-100 Reverse Share Split

Indeterminate GlobeNewswire
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
Nov. 19, 2025

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Vista Physical Therapy Expands North Texas Footprint With Two New Outpatient Clinics in Rockwall and Frisco
Nov. 19, 2025

Vista Physical Therapy Expands North Texas Footprint With Two New Outpatient Clinics in Rockwall and Frisco

Indeterminate GlobeNewswire
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”
Nov. 19, 2025

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”

Indeterminate GlobeNewswire
New Report Introduces First Legal Blueprint for Climate-Resilient Water and Sanitation in the U.S.
Nov. 19, 2025

New Report Introduces First Legal Blueprint for Climate-Resilient Water and Sanitation in the U.S.

Indeterminate GlobeNewswire
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses
Nov. 19, 2025

ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

Indeterminate GlobeNewswire
The American Society of Pain and Neuroscience (ASPN) Issues Consensus Guidelines on Peripheral Nerve Stimulation
Nov. 19, 2025

The American Society of Pain and Neuroscience (ASPN) Issues Consensus Guidelines on Peripheral Nerve Stimulation

Indeterminate GlobeNewswire
Spherix Global Insights Reports Rapidly Evolving U.S. PNH Market as Ultomiris Prescriptions Reach Parity with Iron Supplements
Nov. 19, 2025

Spherix Global Insights Reports Rapidly Evolving U.S. PNH Market as Ultomiris Prescriptions Reach Parity with Iron Supplements

Indeterminate GlobeNewswire
Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update
Nov. 19, 2025

Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update

Indeterminate GlobeNewswire
Gene Therapy for Ocular Rare Disease Market to Exhibit Phenomenal Growth During the Forecast Period (2025–2034) Due to Expanding Pipeline and Clinical Trial Activities | DelveInsight
Nov. 19, 2025

Gene Therapy for Ocular Rare Disease Market to Exhibit Phenomenal Growth During the Forecast Period (2025–2034) Due to Expanding Pipeline and Clinical Trial Activities | DelveInsight

Indeterminate GlobeNewswire
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Nov. 19, 2025

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions